![]() |
|
| | ||||
| I am one Join Date: Dec 2004 Location: Enshrouded by a luciferous arbor
Stats: 6'3" 215 lbs
Posts: 1,367
![]() | I've read that some doctors will prescribe 6-12 weeks of nolva at 20-30mg to abrogate gyno. Since we know that nolva isn't the safest thing in the world to run that long, it seems toremifene will be a useful substitution. Looking forward to giving it a shot. I have also read of 60mg/d as a starting dose. I suppose it would work as well at that dose to atrophy gyno. | |||
| | ||||
| | ||||
| Registered User Join Date: Jan 2006
Posts: 138
![]() | i was reading through btpb and saw that does not hinder glucose storage and gh release like other serms ,also on the plus side fareston has positive effect on cholesterol. But it hinders LH/FSH production | |||
| | ||||
| | |||||
| Board Supporter Join Date: Jan 2005 Location: NC
Stats: 5'9" 204 lbs
Posts: 1,018
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Quote:
| ||||
| | |||||
| | ||||
| Board Supporter Join Date: Jan 2005 Location: NC
Stats: 5'9" 204 lbs
Posts: 1,018
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | As posted by Max-rot98 Endocrine mechanism of action of toremifene at the level of the central nervous system in advanced breast cancer patients. Szamel I, Hindy I, Budai B, Kangas L, Hajba A, Lammintausta R. Clinical Research Department, National Institute of Oncology, Budapest, Hungary. PURPOSE: To differentiate the antagonistic and agonistic effect of toremifene at the level of the hypothalamus-hypophysis axis a leutinizing hormone-releasing hormone (LHRH) test was performed during a phase II clinical trial. METHODS: In 15 postmenopausal patients with advanced breast cancer, follicle-stimulating hormone (FSH) and LH release--induced by an LHRH agonist (Suprefact injection, 0.5 mg s.c.)--was monitored during a 16-week period of toremifene treatment (60 mg/day p.o.). Prolactin, estradiol, and sex hormone-binding globulin (SHBG) levels were also measured. The functional test was carried out prior to toremifene therapy and then 4, 8, 12, and 16 weeks afterward. RESULTS: The drug sensitized the pituitary to the action of the gonadotrophins; the LHRH-induced FSH and LH release showed a considerably increasing tendency during the toremifene therapy. Estradiol levels decreased statistically significantly and SHBG levels showed a statistically significant increase. A decreased level of prolactin is the sign of an antiestrogenic effect of toremifene on the hypophysis and, as a result, provides evidence for a direct influence of toremifene upon the pituitary. An increase in LH and prolactin release in response to the LHRH test was characteristic in the responders. CONCLUSION: According to the LHRH test, the antagonistic effect of toremifene seems to be more dominant than the concomitantly existing agonistic property. Neither clinical nor endocrinological side effects could be observed at the level of the CNS during a prolonged period of toremifene administration. PMID: 9685060 [PubMed - indexed for MEDLINE] __________________ | |||
| | ||||
| | |||||
| Board Supporter Join Date: Apr 2005 Age: 26
Posts: 738
![]() | Quote:
| ||||
| | |||||
| | ||||
| Registered User Join Date: Jan 2006
Posts: 138
![]() | read it out of building the perfect beast by author l rea page 68. also found this: Potential New Antiestrogens for the Treatment of Breast Cancer Sally A. Felton, PharmD Sally A. Felton is Oncology Specialty Practice Resident, University of Maryland Cancer Center, Baltimore. Toremifene exhibits weak estrogenic effects, resulting in a slight decrease in levels of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) and an increase in sex hormone-binding globulin (SHBG).23,24 http://www.meniscus.com/web/publicat...t3_152.html#f1 | |||
| | ||||
| | |||||
| Coug Got a haircut!! Join Date: Aug 2004 Location: Either the gym or Thermochat Age: 26
Posts: 1,197
![]() | Quote:
| ||||
| | |||||
| | |||||
| Registered User Join Date: Nov 2005 Location: Ohio Age: 27
Stats: 5'11" 217 lbs
Posts: 177
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Quote:
| ||||
| | |||||
|